A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies
1 other identifier
observational
100
1 country
1
Brief Summary
Microorganisms maintain a complex interrelationship with the human body, influencing each other. In recent years, people have gradually realized that the formation of the pediatric microecosystem is closely related to the development of gastrointestinal and even systemic immunity in children. The establishment of the pediatric microecosystem during childhood has significant implications for various diseases in adulthood. They are crucial for the host's nutrition, metabolism, resistance to pathogens, and immune function. Increasing evidence supports the association between gut microbiota abnormalities and the pathophysiology of food allergies, but the conclusions of existing clinical efficacy studies remain controversial. Previous research by the team has found that the gut microbiome has a clear impact on the occurrence and development of digestive and allergic diseases in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 8, 2025
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
March 3, 2025
February 1, 2025
3 years
February 8, 2025
February 26, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Intestinal microbiome analysis
The fecal samples from all participants will be collected and subjected to high-throughput metagenomic sequencing in order to elucidate the characteristics and composition of the intestinal microbiome in children with food allergies.
The time point of confirming food allergy and the age of 36 months
Intestinal microbiome metabolites analysis
This will be detected and analyzed by liquid chromatography-mass spectrometry (LC-MS) non-targeted metabolomics to analyze the metabolites of the intestinal microbiome.
The time point of confirming food allergy and the age of 36 months
Secondary Outcomes (4)
Differences in clinical symptoms
36 months of age
The percentile number of height of children at different groups
The time point of confirming food allergy and the age of 36 months
The percentile number of head circumference of children at different group
The time point of confirming food allergy and the age of 36 months
The percentile number of weight of children at different groups
The time point of confirming food allergy and the age of 36 months
Study Arms (1)
Food-allergic children
Children diagnosed with food allergies
Eligibility Criteria
Diagnosed with food allergy children aged 1-36 months old
You may qualify if:
- Children aged 1-36 months old
- Both men and women;
- The child's legal guardian signed the informed consent to participate in the study.
- The legal guardian of the child commits to follow the study procedures and cooperate with the entire study process
You may not qualify if:
- Probiotics or antibiotics within 1 month
- Associated with clinically significant abnormalities in liver and kidney function, nervous system, respiratory system, and coagulation function as determined by the investigator
- Unstable vital signs;
- Have other underlying medical conditions
- Individuals deemed unsuitable for this clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Biospecimen
faeces
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 36 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2025
First Posted
March 3, 2025
Study Start
February 1, 2025
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
March 3, 2025
Record last verified: 2025-02